AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24687355 — intervention group
Group type: COMPARATOR
Intervention: Standard infant formula (control)
Number of subjects: 600
Study 21281959 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT)
Number of subjects: 18
Study 21281959 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 19097848 — intervention group
Group type: COMPARATOR
Intervention: 10-day antibiotic therapy
Number of subjects: 30
Study 19097848 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day antibiotic therapy
Number of subjects: 30
Study 16651505 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilot studies
Number of subjects: 0
Study 16651505 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 12590356 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone 2-6 mg/day
Number of subjects: 377
Study 12590356 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine 5-20 mg/day
Number of subjects: 377
Study 10565798 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg/day)
Number of subjects: 157
Study 10565798 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline (50-250 mg/day, mean 138.1 mg/day)
Number of subjects: 157
Study 8908893 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed postcard reminders
Number of subjects: 107
Study 8908893 — intervention group
Group type: COMPARATOR
Intervention: Control group (no postcard reminders)
Number of subjects: 107
Study 1833917 — intervention group
Group type: EXPERIMENTAL
Intervention: Steam sterilization
Number of subjects: 200
Study 1833917 — intervention group
Group type: EXPERIMENTAL
Intervention: Lyophilization
Number of subjects: 200
Study 1833917 — intervention group
Group type: EXPERIMENTAL
Intervention: Lyophilization + gamma irradiation
Number of subjects: 200
Study 1833917 — intervention group
Group type: EXPERIMENTAL
Intervention: Lyophilization + gamma irradiation in argon
Number of subjects: 200
Study 1833917 — intervention group
Group type: COMPARATOR
Intervention: ‐25 degrees C deep freezing (control group)
Number of subjects: 200
Study 6136695 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination cytotoxic chemotherapy (intravenous cyclophosphamide, methotrexate, and fluorouracil)
Number of subjects: 368
Study 6136695 — intervention group
Group type: COMPARATOR
Intervention: No chemotherapy or conventionally timed chemotherapy
Number of subjects: 368
Study 31493951 — intervention group
Group type: EXPERIMENTAL
Intervention: AdtFMD vaccine (commercial vaccine vector expressing capsid proteins of FMDV strain A24 Cruzeiro)
Number of subjects: 0
Study 27481104 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized exercise prescription (intensity that 'feels good' to the individual for 8 weeks during daily Physical Education)
Number of subjects: 0
Study 27481104 — intervention group
Group type: COMPARATOR
Intervention: Moderate-intensity exercise prescription (target heart rate range 60-80% of HR max for 8 weeks during daily Physical Education)
Number of subjects: 0
Study 26838998 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise and fall prevention self-management intervention (individualised exercise program with motivational interviewing, plus fall prevention education through individualised advice or group-based 'Stepping On' program).
Number of subjects: 350
Study 26838998 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 350
Study 26838998 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise and fall prevention self-management intervention.
Number of subjects: 350
Study 24134709 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive self-help version of 'Balance', online multi-session follow-up program
Number of subjects: 244
Study 24134709 — intervention group
Group type: COMPARATOR
Intervention: Brief self-help version of 'Balance', online single session screening procedure
Number of subjects: 244
Study 22495590 — intervention group
Group type: EXPERIMENTAL
Intervention: Sympathetic inhibition via clonidine (48 h transdermal administration) during hypoxia
Number of subjects: 10
Study 22495590 — intervention group
Group type: COMPARATOR
Intervention: Hypoxia (FIO₂ =0.11)
Number of subjects: 10
Study 22495590 — intervention group
Group type: COMPARATOR
Intervention: Normoxia (FIO₂ =0.21)
Number of subjects: 10
Study 22495590 — intervention group
Group type: COMPARATOR
Intervention: Normoxia and sympathetic inhibition
Number of subjects: 10
Study 22495590 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia and sympathetic inhibition
Number of subjects: 10
Study 19615155 — intervention group
Group type: EXPERIMENTAL
Intervention: 13C-methacetin breath test (13C-MBT)
Number of subjects: 69
Study 17445031 — intervention group
Group type: EXPERIMENTAL
Intervention: Hindmilk feeding
Number of subjects: 0
Study 17445031 — intervention group
Group type: COMPARATOR
Intervention: Composite breast milk feeding (Control)
Number of subjects: 0
Study 15823786 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean Lifestyle Program
Number of subjects: 279
Study 12452301 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin (1 mg/kg twice daily by SC injection)
Number of subjects: 142
Study 12452301 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalteparin (120 IU/kg twice daily by SC injection)
Number of subjects: 142
Study 9607384 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg tasosartan
Number of subjects: 278
Study 9607384 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg tasosartan
Number of subjects: 278
Study 9607384 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg tasosartan
Number of subjects: 278
Study 9607384 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg tasosartan
Number of subjects: 278
Study 9607384 — intervention group
Group type: EXPERIMENTAL
Intervention: All tasosartan dosages
Number of subjects: 278
Study 9607384 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 278
Study 8169569 — intervention group
Group type: EXPERIMENTAL
Intervention: Active marijuana cigarettes (2.3% delta 9-THC)
Number of subjects: 0
Study 8169569 — intervention group
Group type: COMPARATOR
Intervention: Marijuana cigarettes with varying tetrahydrocannabinol content (0.0%, 2.0%, and 3.5%)
Number of subjects: 0
Study 8169569 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice between previously sampled doses (0.0%, 2.0%, and 3.5%)
Number of subjects: 0
Study 8169569 — intervention group
Group type: COMPARATOR
Intervention: Marijuana cigarettes with varying tetrahydrocannabinol content
Number of subjects: 0
Study 2899108 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics
Number of subjects: 536
Study 2899108 — intervention group
Group type: EXPERIMENTAL
Intervention: Time of shaving the operation site
Number of subjects: 536
Study 2899108 — intervention group
Group type: EXPERIMENTAL
Intervention: Type of theatre ventilation
Number of subjects: 536
Study 2899108 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of operation
Number of subjects: 536
Study 2899108 — intervention group
Group type: EXPERIMENTAL
Intervention: Season
Number of subjects: 536
Study 2899108 — intervention group
Group type: EXPERIMENTAL
Intervention: Age of patient
Number of subjects: 536
Study 2899108 — intervention group
Group type: EXPERIMENTAL
Intervention: Sex of patient
Number of subjects: 536
Study 2899108 — intervention group
Group type: EXPERIMENTAL
Intervention: Carriage of Staphylococcus aureus
Number of subjects: 536
Study 2899108 — intervention group
Group type: EXPERIMENTAL
Intervention: Airborne bacterial count
Number of subjects: 536
Study 2899108 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of bacteria in the wound
Number of subjects: 536
Study 31753745 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative compression (compression stockings continuously for two days, then during the daytime for five days)
Number of subjects: 177
Study 31753745 — intervention group
Group type: COMPARATOR
Intervention: No compression
Number of subjects: 177
Study 31753745 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative compression
Number of subjects: 177
Study 31497988 — intervention group
Group type: COMPARATOR
Intervention: Oral alcohol administration (exact dosage not specified)
Number of subjects: 260
Study 31497988 — intervention group
Group type: COMPARATOR
Intervention: Oral alcohol administration
Number of subjects: 260
Study 28064029 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical methods for adjusting for baseline variables (specific methods not detailed)
Number of subjects: 0
Study 28064029 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardization methods from recent statistics literature
Number of subjects: 0
Study 28064029 — intervention group
Group type: EXPERIMENTAL
Intervention: Software in R and Stata for implementing statistical methods
Number of subjects: 0
Study 25526758 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin degludec
Number of subjects: 13
Study 25526758 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 13
Study 23512773 — intervention group
Group type: EXPERIMENTAL
Intervention: Intragastric balloon (IGB) for 6 months with 12 month behavioral modification
Number of subjects: 66
Study 23512773 — intervention group
Group type: COMPARATOR
Intervention: Behavioral modification alone (Control Group)
Number of subjects: 66
Study 21418261 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium bifidum MIMBb75
Number of subjects: 122
Study 21418261 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study 19648776 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% dexpanthenol ointment
Number of subjects: 18
Study 19648776 — intervention group
Group type: COMPARATOR
Intervention: Placebo ointment (vehicle without dexpanthenol)
Number of subjects: 18
Study 17918695 — intervention group
Group type: EXPERIMENTAL
Intervention: TB3 (Thera-Band training three times/week)
Number of subjects: 30
Study 17918695 — intervention group
Group type: EXPERIMENTAL
Intervention: TB5 (Thera-Band training five times/week)
Number of subjects: 30
Study 17918695 — intervention group
Group type: COMPARATOR
Intervention: CON (Control group)
Number of subjects: 30
Study 15168433 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with close friends from the target group
Number of subjects: 2
Study 15168433 — intervention group
Group type: COMPARATOR
Intervention: Participants without close friends from the target group
Number of subjects: 2
Study 11379804 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal IL-6 (0, 0.01, 0.1, and 1 microg/mL)
Number of subjects: 30
Study 11379804 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 30
Study 9224439 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral treatment emphasizing patient pleasant events
Number of subjects: 72
Study 9224439 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral treatment emphasizing caregiver problem solving
Number of subjects: 72
Study 9224439 — intervention group
Group type: COMPARATOR
Intervention: Typical care condition
Number of subjects: 72
Study 9224439 — intervention group
Group type: COMPARATOR
Intervention: Wait list control
Number of subjects: 72
Study 8128463 — intervention group
Group type: EXPERIMENTAL
Intervention: Bubble oxygenation without an arterial line filter (Group I, n = 17)
Number of subjects: 54
Study 8128463 — intervention group
Group type: EXPERIMENTAL
Intervention: Bubble oxygenation with an arterial filter (Group II, n = 17)
Number of subjects: 54
Study 8128463 — intervention group
Group type: EXPERIMENTAL
Intervention: Membrane oxygenation without an arterial filter (Group III, n = 20)
Number of subjects: 54
Study 8128463 — intervention group
Group type: EXPERIMENTAL
Intervention: Membrane oxygenator group
Number of subjects: 54
Study 3611398 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam (4 mg orally)
Number of subjects: 50
Study 3611398 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 2667015 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmethylimipramine (DMI) 50 mg oral test dose
Number of subjects: 15
Study 2667015 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline (AMI)
Number of subjects: 15
Study 31520258 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupuncture therapy
Number of subjects: 60
Study 31520258 — intervention group
Group type: COMPARATOR
Intervention: No acupuncture therapy (Control)
Number of subjects: 60
Study 25701102 — intervention group
Group type: EXPERIMENTAL
Intervention: Health coaching intervention delivered by medical students
Number of subjects: 29
Study 26074402 — intervention group
Group type: EXPERIMENTAL
Intervention: N1b patients
Number of subjects: 0
Study 26074402 — intervention group
Group type: EXPERIMENTAL
Intervention: N1a patients
Number of subjects: 0
Study 26074402 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumor size
Number of subjects: 0
Study 26074402 — intervention group
Group type: EXPERIMENTAL
Intervention: pT3b and pT4a tumors with N1b
Number of subjects: 0
Study 23315596 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 3195
Study 23315596 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3195
Study 21702877 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant massage intervention (daily for 10 weeks)
Number of subjects: 0
Study 21702877 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 19843033 — intervention group
Group type: EXPERIMENTAL
Intervention: Conversion from cyclosporine (CsA) to sirolimus
Number of subjects: 193
Study 19843033 — intervention group
Group type: COMPARATOR
Intervention: Continue cyclosporine (CsA)
Number of subjects: 193
Study 16739838 — intervention group
Group type: EXPERIMENTAL
Intervention: He's Santong needling method
Number of subjects: 319
Study 16739838 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture at 12 points of the hand and foot
Number of subjects: 319
Study 15195986 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric knee extension strength
Number of subjects: 0
Study 15195986 — intervention group
Group type: EXPERIMENTAL
Intervention: Habitual physical activity (predominantly household work)
Number of subjects: 0
Study 15195986 — intervention group
Group type: EXPERIMENTAL
Intervention: Timed 'Get‐Up‐and‐Go' test (TGUG)
Number of subjects: 0
Study 15195986 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Coopertest (COOP)
Number of subjects: 0
Study 11717612 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 122
Study 11717612 — intervention group
Group type: COMPARATOR
Intervention: Control (no ramipril)
Number of subjects: 122
Study 9386211 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous combined HRT with Kliogest (daily tablet for 9 months)
Number of subjects: 2151
Study 9386211 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous combined HRT with Kliogest
Number of subjects: 2151
Study 7952793 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled salmeterol 12.5, 50 and 100 micrograms
Number of subjects: 8
Study 7952793 — intervention group
Group type: COMPARATOR
Intervention: Inhaled salbutamol 200 micrograms
Number of subjects: 8
Study 7952793 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled salmeterol 50 and 100 micrograms
Number of subjects: 8
Study 7952793 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled salmeterol and salbutamol
Number of subjects: 8
Study 2438095 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of salbutamol and theophylline
Number of subjects: 25
Study 2438095 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (aerosol nebulizers)
Number of subjects: 25
Study 2438095 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 29035598 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentric (CONC) cycling at 30% intensity
Number of subjects: 10
Study 29035598 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentric (CONC) cycling at 60% intensity
Number of subjects: 10
Study 29035598 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentric (CONC) cycling at 80% intensity
Number of subjects: 10
Study 29035598 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentric (CONC) cycling at maximal intensity
Number of subjects: 10
Study 29035598 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentric (CONC) cycling
Number of subjects: 10
Study 29035598 — intervention group
Group type: COMPARATOR
Intervention: Eccentric (ECC) cycling
Number of subjects: 10
Study 26397235 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine infusion (1.5 mg/kg IV bolus followed by 2 mg/kg/h infusion until end of surgery)
Number of subjects: 94
Study 26397235 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (same volume as lidocaine)
Number of subjects: 94
Study 24534082 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise program (12-week, thrice weekly)
Number of subjects: 28
Study 24534082 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 28
Study 22948049 — intervention group
Group type: EXPERIMENTAL
Intervention: ABVD chemotherapy
Number of subjects: 287
Study 22948049 — intervention group
Group type: COMPARATOR
Intervention: Stanford V chemotherapy
Number of subjects: 287
Study 20063935 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive function assessment (not specified dosage or duration)
Number of subjects: 0
Study 17400154 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiographic embolization
Number of subjects: 0
Study 17400154 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrinogen or recombinant activated factor VII (rFVIIa)
Number of subjects: 0
Study 15694083 — intervention group
Group type: COMPARATOR
Intervention: Oral misoprostol 25 microg every 3 days for a maximum of three doses
Number of subjects: 49
Study 15694083 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral misoprostol 50 microg every 3 days for a maximum of three doses
Number of subjects: 49
Study 12798694 — intervention group
Group type: EXPERIMENTAL
Intervention: RT (Radiation Therapy)
Number of subjects: 256
Study 12798694 — intervention group
Group type: EXPERIMENTAL
Intervention: RT + HYST (Radiation Therapy with Extrafascial Hysterectomy)
Number of subjects: 256
Study 12798694 — intervention group
Group type: EXPERIMENTAL
Intervention: RT + HYST
Number of subjects: 256
Study 12798694 — intervention group
Group type: COMPARATOR
Intervention: RT
Number of subjects: 256
Study 10365928 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical azelaic acid 20% cream
Number of subjects: 40
Study 10365928 — intervention group
Group type: COMPARATOR
Intervention: Topical metronidazole 0.75% cream
Number of subjects: 40
Study 7582291 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral Nutrition (EN)
Number of subjects: 24
Study 7582291 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Parenteral Nutrition (TPN)
Number of subjects: 24
Study 7582291 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 24
Study 1742442 — intervention group
Group type: EXPERIMENTAL
Intervention: Cox proportional hazards model with added variable plot
Number of subjects: 0
Study 1742442 — intervention group
Group type: EXPERIMENTAL
Intervention: Cox proportional hazards model with constructed variable plot
Number of subjects: 0
Study 1742442 — intervention group
Group type: EXPERIMENTAL
Intervention: Cox proportional hazards model
Number of subjects: 0
Study 6756934 — intervention group
Group type: EXPERIMENTAL
Intervention: Piretanide 1.0 mg
Number of subjects: 34
Study 6756934 — intervention group
Group type: COMPARATOR
Intervention: Frusemide 6.25 mg
Number of subjects: 34
Study 31551393 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated medical assessment and surgical repair with a goal of surgery within 6 hours of diagnosis
Number of subjects: 1998
Study 31551393 — intervention group
Group type: COMPARATOR
Intervention: Standard care where a repair typically occurs 24 to 48 hours after diagnosis
Number of subjects: 1998
Study 29116999 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous venovenous hemofiltration and hemoperfusion
Number of subjects: 110
Study 29116999 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 110
Study 26955672 — intervention group
Group type: EXPERIMENTAL
Intervention: Hebi Recipe (HR) plus Methotrexate (MTX)
Number of subjects: 63
Study 26955672 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (MTX) alone
Number of subjects: 63
Study 24743706 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental therapies (specific therapies not detailed)
Number of subjects: 244
Study 24743706 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition of cetuximab in the KRAS, BRAF wild-type cohort
Number of subjects: 244
Study 24743706 — intervention group
Group type: COMPARATOR
Intervention: FOLFIRI chemotherapy (common control arm)
Number of subjects: 244
Study 23146806 — intervention group
Group type: EXPERIMENTAL
Intervention: Chaiqinchengqi decoction (CQCQD)
Number of subjects: 35
Study 23146806 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 19728201 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma Control Questionnaire (ACQ)
Number of subjects: 0
Study 19728201 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma Control Scoring System (ACSS)
Number of subjects: 0
Study 19728201 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma Control Test (ACT)
Number of subjects: 0
Study 19728201 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma Therapy Assessment Questionnaire (ATAQ)
Number of subjects: 0
Study 19728201 — intervention group
Group type: EXPERIMENTAL
Intervention: Lara Asthma Symptom Scale (LASS)
Number of subjects: 0
Study 17975232 — intervention group
Group type: EXPERIMENTAL
Intervention: PCEA with meperidine (2 mg/mL) + adrenaline (2 µg/mL)
Number of subjects: 46
Study 17975232 — intervention group
Group type: COMPARATOR
Intervention: PCEA with meperidine (2 mg/mL) alone
Number of subjects: 46
Study 15125570 — intervention group
Group type: EXPERIMENTAL
Intervention: Citric acid in the tablet matrix (10-15%)
Number of subjects: 0
Study 15125570 — intervention group
Group type: COMPARATOR
Intervention: Citric acid in granule cores
Number of subjects: 0
Study 15125570 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (model drug)
Number of subjects: 0
Study 11756070 — intervention group
Group type: EXPERIMENTAL
Intervention: Purified isoflavones (genistein, daidzein, glycitein)
Number of subjects: 30
Study 11756070 — intervention group
Group type: EXPERIMENTAL
Intervention: Purified isoflavones (genistein, daidzein)
Number of subjects: 30